Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Chlorpheniramine, phenylpropanolamine drug combination

Insgesamt 661 ergebnisse

NCT02859246

Abgeschlossen

Mucinex® for Treatment of Filamentary Keratitis

Bedingungen: Filamentary Keratitis
NCT03633487

Abgeschlossen

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Bedingungen: Healthy Subjects
NCT03649750

Abgeschlossen

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

Bedingungen: Healthy Subjects
NCT03642262

Abgeschlossen

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Bedingungen: Healthy Subjects
NCT03644108

Abgeschlossen

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Bedingungen: Healthy Subjects
NCT04767074

Rekrutierung

A Non-pharmacological Cough Control Therapy

Bedingungen: Cough; ILD; Pulmonary Disease; Pulmonary Fibrosis
NCT03725085

Abgeschlossen

Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion

Bedingungen: Healthy Subjects
NCT03644095

Abgeschlossen

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers

Bedingungen: Healthy Subjects
NCT03706300

Abgeschlossen

Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions

Bedingungen: Healthy
NCT01537081

Abgeschlossen

Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

Bedingungen: Acute Upper Respiratory Tract Infection
NCT03633448

Abgeschlossen

Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents

Bedingungen: Healthy Subjects
NCT03642873

Abgeschlossen

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate

Bedingungen: Healthy Subjects
NCT01202279

Abgeschlossen

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Bedingungen: Acute Upper Respiratory Track Infection
NCT02572375

Abgeschlossen

Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study

Bedingungen: Cough
NCT02396459

Noch nicht rekrutiert

Triac Trial II in MCT8 Deficiency Patients

Bedingungen: Allan-Herndon-Dudley Syndrome
NCT02060474

Abgeschlossen

Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients

Bedingungen: Allan-Herndon-Dudley Syndrome
NCT01584804

Unbekannter Status

Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma

Bedingungen: Asthma
NCT01364467

Abgeschlossen

The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study

Bedingungen: Chronic Rhinitis
NCT01114581

Abgeschlossen

Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection

Bedingungen: Acute Respiratory Infection
NCT00902707

Abgeschlossen

Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung

Bedingungen: Mucociliary Clearance
NCT03643575

Abgeschlossen

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.

Bedingungen: Healthy Subjects
NCT01562548

Abgeschlossen

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

Bedingungen: Upper Back Pain
NCT03783988

Unbekannter Status

Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids

Bedingungen: Skin Atrophy
NCT01046136

Abgeschlossen

Mucinex Exploratory Cold Study

Bedingungen: Common Cold
NCT01257243

Abgeschlossen

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

Bedingungen: Cough